| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enhabit, Inc. (EHAB) has 16 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. EHAB is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 606.7K | $8.37M | - | |
| CFO | 175.5K | $2.42M | - | |
| Dir | 139.7K | $1.93M | - | |
| VP | 137.1K | $1.89M | - | |
| Other | 93.1K | $1.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | Hoeflinger Erin | Director | Buy | 2,000 | $9.00 | $18,000.00 | +7.0% | -9.6% | +17.0% | |
| May 10, 2024 | Bolton Jeffrey63 | Director | Buy | 10,000 | $8.24 | $82,400.00 | +31.0% | +2.2% | +23.3% | |
| Mar 1, 2024 | Langham Ronald Leroy Jr | EVP Clinical Excel. &Strategy | Sell | 634 | $8.81 | $5,585.54 | -1.1% | +4.4% | -5.0% | |
| May 26, 2023 | Bolton Jeffrey63 | Director | Buy | 2,000 | $11.61 | $23,220.00 | +11.4% | +10.6% | -23.5% | |
| May 22, 2023 | Shaw L Edward Jr | Director | Buy | 10,000 | $11.98 | $119,800.00 | +34.5% | -3.5% | -23.8% | |
| May 18, 2023 | Hoeflinger Erin | Director | Buy | 2,100 | $11.82 | $24,822.00 | +15.4% | -4.5% | -31.3% | |
| May 18, 2023 | Langham Ronald Leroy Jr | EVP Clinical Excel. &Strategy | Buy | 10,000 | $11.99 | $119,900.00 | +29.1% | -4.5% | -31.3% | |
| May 17, 2023 | Bolton Jeffrey63 | Director | Buy | 2,000 | $11.80 | $23,600.00 | +12.8% | -5.9% | -30.6% | |
| Nov 18, 2022 | Bolton Jeffrey63 | Director | Buy | 1,000 | $12.69 | $12,690.00 | +6.9% | +22.6% | -23.5% | |
| Nov 9, 2022 | Bolton Jeffrey63 | Director | Buy | 4,000 | $12.82 | $51,280.00 | +17.2% | +15.8% | -26.1% |